Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
ADC ID |
DRG0LQFXO
|
|||||
---|---|---|---|---|---|---|
ADC Name |
Anti-FucGM1 mAb-IIIa-03
|
|||||
Synonyms |
Anti-FucGM1-mAb-IIIa-03
Click to Show/Hide
|
|||||
Organization |
Bristol Myers Squibb Co.
|
|||||
Drug Status |
Investigative
|
|||||
Indication |
In total 1 Indication(s)
Small cell lung cancer [ICD11:2C25]
Investigative
|
|||||
Drug-to-Antibody Ratio |
2
|
|||||
Antibody Name |
Anti-FucGM1 mAb
|
Antibody Info | ||||
Antigen Name |
Fucosylated monosialotetrahexosylganglioside (FucGM1)
|
Antigen Info | ||||
Payload Name |
Undisclosed
|
|||||
Linker Name |
Anti-FucGM1 mAb linker
|
|||||
Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 0.5-1.0 nM | Positive FucGM1 expression (FucGM1+++/++) | ||
Method Description |
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.
Click to Show/Hide
|
||||
In Vitro Model | Lung small cell carcinoma | NCI-H187 cells | CVCL_1501 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | 0.6-1.7 nM | Positive FucGM1 expression (FucGM1+++/++) | ||
Method Description |
The MTS cell proliferation assay was performed as follows: CellTiter 96 Aqueous Non-Radioactive Cell proliferation Kit is used to determine the number of viable cells in cell proliferation assay. Tumor cells are plated at certain seeding densities in sterile 384-well black clear bottom Matrix plates at 40 uL per well and incubated overnight at 37°C in 5% CO2 before assaying.
Click to Show/Hide
|
||||
In Vitro Model | Small cell lung carcinoma | DMS-79 cells | CVCL_1178 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.